一个国际,以专家为基础的德尔菲共识文件关于跨动脉再血管化 (TCAR) 争议性问题
Kosmas I Paraskevas1, Ali F AbuRahma2, Christopher J Abularrage3
1Department of Vascular Surgery, Red Cross Hospital, Athens, Greece.
Annals of vascular surgery
|October 16, 2024
概括
穿动脉复血管化 (TCAR) 提供了关于动脉狭窄症管理的指导. 这个德尔菲共识表明,TCAR在事件发生后的14天内是可行的,但需要进一步的研究才能实现最佳使用.
科学领域:
- 血管外科 血管外科
- 干预心脏病学 干预心脏病学
- 神经学 神经学
背景情况:
- 穿动脉复血管化 (TCAR) 是一种新兴的替代 carotid endarterectomy (CEA) 和 transfemoral carotid动脉支架 (TFCAS) 的替代方案.
- 关于TCAR程序的指示和禁忌,仍然存在未解决的问题.
- 本文通过专家共识解决了这些不确定性.
研究的目的:
- 提供基于专家的指导,关于TCAR的适用和适用情况.
- 为了澄清TCAR在治疗动脉狭窄症中的作用.
- 确定需要进一步研究的领域.
主要方法:
- 一个三轮的德尔菲共识过程,涉及29名国际专家.
- 第1轮: 专家意见的探索.
- 第2轮和第3轮:传播文献评论和最终投票以达成共识.
主要成果:
- 可以在脑血管事件发生后的14天内进行TCAR,避免在最初的48小时内进行.
- TCAR不应该取代CEA或TFCAS,因为每个都有特定的指示.
- 在80岁以上的有症状的患者和在CEA/TFCAS后的静止症治疗中,TCAR可能比TFCAS更受青.
结论:
- 这个德尔菲共识为管理动脉狭窄提供了决策援助.
- 确定的领域需要通过未来的研究和随机对照试验 (RCT) 进行进一步的调查.
- 需要额外的证据来解决有关TCAR.CAR的剩余问题.
相关概念视频
Peripheral Artery Disease III: Interprofessional Care
3
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
3
Aneurysm III: Interprofessional Care
3
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
3
Coronary Artery Disease V: Surgical Management
3
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3


